McLeod Karen A, McLean Andrew
Royal Hospital for Sick Children, Yorkhill, Glasgow, United Kingdom.
Pacing Clin Electrophysiol. 2012 Jan;35(1):e20-3. doi: 10.1111/j.1540-8159.2010.02865.x. Epub 2010 Aug 17.
The subcutaneous implantable cardioverter defibrillator (S-ICD) from Cameron Health (San Clemente, CA, USA) does not require a lead to be placed on or in the heart. Such a device, being subcutaneous, has potential benefits in children who require ICDs where problems largely relate to transvenous or epicardial leads and inappropriate shocks. The S-ICD was approved for use in Europe in June 2009 and recently a study commenced to acquire data in 330 patients in order to submit to the FDA. We shall describe the implantation of the S-ICD in two children aged 10 and 12 years at our institution.
美国加利福尼亚州圣克莱门特市卡梅隆健康公司生产的皮下植入式心律转复除颤器(S-ICD)无需将电极导线置于心脏上或心脏内。这种皮下装置对于需要植入心律转复除颤器的儿童具有潜在益处,因为这些儿童面临的问题主要与经静脉或心外膜电极导线以及不适当电击有关。S-ICD于2009年6月在欧洲获批使用,最近启动了一项针对330名患者的数据采集研究,以便提交给美国食品药品监督管理局(FDA)。我们将描述在我们机构为两名年龄分别为10岁和12岁的儿童植入S-ICD的情况。